切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (02) : 239 -243. doi: 10.3877/cma.j.issn.2095-3232.2024.02.021

综述

急性胰腺炎评分系统预测病情严重程度的研究进展
胡欣芫1, 杨智義1, 赵成俊1, 张秋雨1, 张挽乾1, 潘佰猛1, 张灵强2,()   
  1. 1. 810001 西宁,青海大学医学院
    2. 810001 西宁,青海大学医学院;810001 西宁,青海大学附属医院肝胆胰外科
  • 收稿日期:2023-10-30 出版日期:2024-04-10
  • 通信作者: 张灵强

Research progress in acute pancreatitis scoring systems in predicting the severity of disease

Xinyuan Hu1, Zhiyi Yang1, Chengjun Zhao1, Qiuyu Zhang1, Wanqian Zhang1, Baimeng Pan1, Lingqiang Zhang2,()   

  1. 1. Medical College of Qinghai University, Xining 810001, China
    2. Medical College of Qinghai University, Xining 810001, China; Department of Hepatobiliary and Pancreatic Surgery, Qinghai University Affiliated Hospital, Xining 810001, China
  • Received:2023-10-30 Published:2024-04-10
  • Corresponding author: Lingqiang Zhang
引用本文:

胡欣芫, 杨智義, 赵成俊, 张秋雨, 张挽乾, 潘佰猛, 张灵强. 急性胰腺炎评分系统预测病情严重程度的研究进展[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 239-243.

Xinyuan Hu, Zhiyi Yang, Chengjun Zhao, Qiuyu Zhang, Wanqian Zhang, Baimeng Pan, Lingqiang Zhang. Research progress in acute pancreatitis scoring systems in predicting the severity of disease[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(02): 239-243.

急性胰腺炎(AP)是在外科临床工作中常见的疾病。其中大多数轻症急性胰腺炎的患者经保守治疗后即可明显缓解,但仍有少数患者可能进展至重症急性胰腺炎(SAP),病死率较高,预后结局差。因此及早评估AP病情对于患者的治疗、预后至关重要。目前临床上常用的预测胰腺炎病情严重程度的评分系统有Ranson评分、APACHE Ⅱ评分、BISAP评分等评分系统。本文对AP现有的评分系统及其相关的改良评分系统近年来的研究进展进行概述。

Acute pancreatitis (AP) is a common disease in clinical practice. A majority of patients with mild AP can be significantly mitigated after conservative treatment, whereas a few patients may progress into severe acute pancreatitis (SAP), which yields high mortality and poor prognosis. Therefore, timely evaluation of the condition of AP is of significance for the treatment and prognosis of patients. At present, Ranson scoring system, APACHE Ⅱ scoring system and BISAP scoring system are commonly employed to predict the severity of pancreatitis in clinical settings. In this article, research progresses in the existing scoring systems for AP and relevant modified scoring systems were reviewed.

[1]
Ranson JH, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis[J]. Surg Gynecol Obstet, 1974, 139(1):69-81.
[2]
Ranson JH, Pasternack BS. Statistical methods for quantifying the severity of clinical acute pancreatitis[J]. J Surg Res, 1977, 22(2):79-91.
[3]
Ong Y, Shelat VG. Ranson score to stratify severity in acute pancreatitis remains valid - old is gold[J]. Expert Rev Gastroenterol Hepatol, 2021, 15(8):865-877.
[4]
Yang CJ, Chen J, Phillips AR, et al. Predictors of severe and critical acute pancreatitis: a systematic review[J]. Dig Liver Dis, 2014, 46(5):446-451.
[5]
Mikó A, Vigh é, Mátrai P, et al. Computed tomography severity index vs. other indices in the prediction of severity and mortality in acute pancreatitis: a predictive accuracy meta-analysis[J]. Front Physiol, 2019(10):1002.
[6]
Luo X, Wang J, Wu Q, et al. A modified Ranson score to predict disease severity, organ failure, pancreatic necrosis, and pancreatic infection in patients with acute pancreatitis[J]. Front Med, 2023(10): 1145471.
[7]
Knaus WA, Draper EA, Wagner DP, et al. APACHEⅡ: a severity of disease classification system[J]. Crit Care Med, 1985, 13(10):818-829.
[8]
Di MY, Liu H, Yang ZY, et al. Prediction models of mortality in acute pancreatitis in adults: a systematic review[J]. Ann Intern Med, 2016, 165(7):482-490.
[9]
Gravante G, Garcea G, Ong SL, et al. Prediction of mortality in acute pancreatitis: a systematic review of the published evidence[J]. Pancreatology, 2009, 9(5):601-614.
[10]
Harshit Kumar A, Singh Griwan M. A comparison of APACHEⅡ,BISAP, Ranson's score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta classification[J]. Gastroenterol Rep, 2018, 6(2):127-131.
[11]
Li W, Ou L, Fu Y, et al. Risk factors for concomitant infectious pancreatic necrosis in patients with severe acute pancreatitis: a systematic review and meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2022, 46(5):101901.
[12]
Larvin M, McMahon MJ. APACHE-Ⅱ score for assessment and monitoring of acute pancreatitis[J]. Lancet, 1989, 2(8656):201-205.
[13]
Pearce CB, Gunn SR, Ahmed A, et al. Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHEⅡ score and C-reactive protein[J]. Pancreatology, 2006, 6(1/2):123-131.
[14]
Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, et al. Comparison of ranson, APACHE Ⅱ and apache Ⅲ scoring systems in acute pancreatitis[J]. Pancreas, 2002, 25(4):331-335.
[15]
Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE Ⅱ, clinical assessment and multiple factor scoring systems[J]. Br J Surg, 1990, 77(11):1260-1264.
[16]
Domínguez-Muñoz JE, Carballo F, García MJ, et al. Evaluation of the clinical usefulness of APACHE Ⅱ and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study[J]. Pancreas, 1993, 8(6):682-686.
[17]
Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study[J]. Lancet, 2000, 355(9219):1955-1960.
[18]
Johnson CD, Toh SK, Campbell MJ. Combination of APACHE-Ⅱ score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis[J]. Pancreatology, 2004, 4(1):1-6.
[19]
Gürleyik G, Emir S, Kiliçoglu G, et al. Computed tomography severity index, APACHEⅡ score, and serum CRP concentration for predicting the severity of acute pancreatitis[J]. JOP, 2005, 6(6):562-567.
[20]
Wu BU, Johannes RS, Sun X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study[J]. Gut, 2008, 57(12):1698-1703.
[21]
Park JY, Jeon TJ, Ha TH, et al. Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(6):645-650.
[22]
Hagjer S, Kumar N. Evaluation of the BISAP scoring system in prognostication of acute pancreatitis - a prospective observational study[J]. Int J Surg, 2018, 54(Pt A):76-81.
[23]
唐豪佑, 刘胜, 胡程俊, 等. 改良客观性BISAP评分对急性胰腺炎严重程度及预后的预测价值[J]. 临床肝胆病杂志, 2021, 37(6):1386-1391.
[24]
Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis[J]. Radiology, 1990, 174(2):331-336.
[25]
廖茜, 何文华, 李佳蓉, 等. CT严重指数和改良CT严重指数对急性胰腺炎严重程度和预后的评估[J]. 中华医学杂志, 2022, 102(26):2011-2017.
[26]
Perez A, Whang EE, Brooks DC, et al. Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis?[J]. Pancreas, 2002, 25(3):229-233.
[27]
Mortele KJ, Wiesner W, Intriere L, et al. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome[J]. AJR Am J Roentgenol, 2004, 183(5):1261-1265.
[28]
高亚洲, 徐之超, 殷国志. CT评分联合CRP检测评估重症急性胰腺炎的预后价值分析[J]. 中国CT和MRI杂志, 2022, 20(1):122-124.
[29]
孙佳欣, 阎曦. 改良CT严重指数联合IL-6预测急性胰腺炎住院死亡[J]. 现代消化及介入诊疗, 2023, 28(2):244-248.
[30]
陈露, 付丽媛, 许尚文. CT评估脂肪坏死联合CT严重指数评分对急性胰腺炎严重程度和预后的预测价值[J]. 中国CT和MRI杂志, 2023, 21(3):119-120, 138.
[31]
Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7):707-710.
[32]
Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients[J]. JAMA, 2001, 286(14):1754-1758.
[33]
Khwannimit B. Serial evaluation of the MODS, SOFA and LOD scores to predict ICU mortality in mixed critically ill patients[J]. Chotmaihet Thangphaet, 2008, 91(9):1336-1342.
[34]
Anami EH, Grion CM, Cardoso LT, et al. Serial evaluation of SOFA score in a Brazilian teaching hospital[J]. Intensive Crit Care Nurs, 2010, 26(2):75-82.
[35]
de Grooth HJ, Geenen IL, Girbes AR, et al. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis[J]. Crit Care, 2017, 21(1):38.
[36]
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1):102-111.
[37]
Tee YS, Fang HY, Kuo IM, et al. Serial evaluation of the SOFA score is reliable for predicting mortality in acute severe pancreatitis[J]. Medicine, 2018, 97(7):e9654.
[38]
Lankisch PG, Weber-Dany B, Hebel K, et al. The harmless acute pancreatitis score: a clinical algorithm for rapid initial stratification of nonsevere disease[J]. Clin Gastroenterol Hepatol, 2009, 7(6):702-705.
[39]
Maisonneuve P, Lowenfels AB, Lankisch PG. The harmless acute pancreatitis score (HAPS) identifies non-severe patients: a systematic review and meta-analysis[J]. Pancreatology, 2021, 21(8):1419-1427.
[40]
Ueda T, Takeyama Y, Yasuda T, et al. Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis[J]. J Gastroenterol, 2009, 44(5):453-459.
[41]
Hamada T, Yasunaga H, Nakai Y, et al. Japanese severity score for acute pancreatitis well predicts in-hospital mortality: a nationwide survey of 17, 901 cases[J]. J Gastroenterol, 2013, 48(12):1384-1391.
[42]
Ikeura T, Horibe M, Sanui M, et al. Validation of the efficacy of the prognostic factor score in the Japanese severity criteria for severe acute pancreatitis: a large multicenter study[J]. United European Gastroenterol J, 2017, 5(3):389-397.
[1] 王晓梅, 刘冰, 马丽琼, 卢祖静, 苗建军. 基于LASSO-Cox回归分析的非轻症急性胰腺炎死亡风险列线图预测模型的建立和临床应用效果分析[J]. 中华普通外科学文献(电子版), 2024, 18(01): 44-50.
[2] 刘政宏, 王凤力, 吉亚君, 高佳. 胃癌中ELK3蛋白的表达与临床病理特征和预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 155-159.
[3] 张琳, 李婷. CRIP1在胃癌中的表达及与临床病理指标和预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 171-175.
[4] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[5] 朱显钟, 李金雨, 于忠英, 温路生. 淋巴结平均直径与无淋巴结转移肾癌病理特征及预后关系研究[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 146-151.
[6] 王振, 黄璐, 郎连群, 岳麓. 血小板和白蛋白/纤维蛋白原比值在晚期非小细胞肺癌贝伐珠单抗二线治疗的临床意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 35-40.
[7] 王婷, 余江. 1 820例罕见病的临床特征分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 68-72.
[8] 郝春艳, 吉泽, 成苏杭, 李文思, 王丹. 血清miR-155联合sCD14水平判断慢性阻塞性肺疾病预后的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 87-90.
[9] 宋玮, 黄修丽, 李鑫, 史雅琼, 张晔, 邓飞, 高燕. 改良衰弱指数对重症肺部感染的预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 119-122.
[10] 王礼光, 严庆, 廖珊, 符荣党, 陈焕伟. 微血管侵犯及手术切缘对肝细胞癌患者术后生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 151-157.
[11] 马振威, 朱博, 刘赋斌, 邓正栋, 王剑明. 血小板和淋巴细胞比值联合CA19-9在胆囊癌术后患者预后评估中的价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 163-168.
[12] 孟塬, 巴合提·卡力甫, 马志刚, 王锦国, 张杰, 李玉鹏, 宋巍, 田广磊, 陈雄. 腹腔镜胆囊切除术难度评分系统在急性胆囊炎治疗中的应用价值[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 169-175.
[13] 夏辉, 戴斌, 冉君, 王威, 龚昭, 周程. DEP结构域蛋白1B在肝细胞癌中的表达及功能[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 205-213.
[14] 陈显育, 曾谣, 莫钊鸿, 翟航, 张广权, 钟造茂, 陈署贤. 生物信息学分析CETP基因在肝癌中表达及其对预后和免疫的影响[J]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 214-219.
[15] 谢鸿, 李娜, 李尚日, 谢涛. 肠道菌群特征对结肠癌化学治疗疗效的影响[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 53-56.
阅读次数
全文


摘要